Anti-TIFA antibody [EPR20925-114]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- 각 태그의 뜻
Be the first to review this product! 리뷰 제출
|
(2 제품이 사용된 논문 )
Rabbit Recombinant Monoclonal TIFA antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications.
대체 명칭 보기
T2BP, TIFA, TRAF-interacting protein with FHA domain-containing protein A, Putative MAPK-activating protein PM14, Putative NF-kappa-B-activating protein 20, TRAF2-binding protein
- WB
Collaborator
Western blot - Anti-TIFA antibody [EPR20925-114] (AB239352)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The image was kindly provided by our collaborator Dr Feng Shao's lab, NIBS.
ab239352 Anti-TIFA antibody [EPR20925-114] was shown to react with TIFA in HEK-293T cells in Western blot. Loss of signal was observed when TIFA knockout sample was used. Wild-type and TIFA knockout samples were subjected to SDS-PAGE. ab239352 was incubated 1 hour at room temperature at 1/1000 dilution . Blots were developed with Donkey Anti-Rabbit IgG, (H+L), Peroxidase conjugated secondary antibody at 1/5000 dilution for 1 hour at room temperature before imaging. Anti-beta Tubulin was used as loading control.
Exposure time : 2 minutes.
All lanes:
Western blot - Anti-TIFA antibody [EPR20925-114] (ab239352) at 1/1000 dilution
Lane 1:
TIFA knockout HEK-293T whole cell lysate at 20 µg
Lane 2:
Wild-type HEK-293T whole cell lysate at 20 µg
Lane 3:
MOLT-4 (human lymphoblastic leukemia t lymphoblast) whole cell lysate at 20 µg
Secondary
All lanes:
Donkey Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/5000 dilution
Predicted band size: 21 kDa
Observed band size: 20 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-TIFA antibody [EPR20925-114] - BSA and Azide free
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TIFA acts as a mediator in various cellular responses by forming signaling complexes. It possesses a threonine-phosphorylation motif necessary for the formation of oligomeric structures which facilitates its interactions with other proteins. Through this TIFA participates in immune response and inflammation regulation contributing to cellular resilience against external stresses.
Pathways
TIFA is an important player in the NF-κB signaling and Toll-like receptor pathways. It regulates protein interactions within these pathways such as TRAF2 and TRAF6 that help propagate proinflammatory signals. The induction of TIFA in these pathways leads to the activation of downstream effectors which result in targeted immune responses.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (2)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Clinical and experimental pharmacology & physiology 52:e70026 PubMed39924309
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:111563 PubMed39868044
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com